Syntone Ventures Llc Outlook Therapeutics, Inc. (OTLK) insider trading activity
Syntone Ventures LLC is of Outlook Therapeutics, Inc.. Currently has a direct ownership of 1.71 Million shares of OTLK, which is worth approximately $2.42 Million. The most recent transaction as insider was on Apr 15, 2024, when has been sold 714,286 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
1.71M
0%
3M change
91.4%
12M change
Total Value Held
$2.42 Million
Syntone Ventures LLC Transaction History
SVL
Syntone Ventures LLC
Cary, NC